ROBERT NELSEN Insider Trading $JUNO Juno Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT NELSEN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT NELSEN. ROBERT NELSEN is in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Syros Pharmaceuticals, Inc. ($SYRS) and Director in Juno Therapeutics, Inc. ($JUNO) and Director in Bellerophon Therapeutics, Inc. ($BLPH) and Director in Sage Therapeutics, Inc. ($SAGE) and in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Sienna Biopharmaceuticals, Inc. ($SNNA) and Director in Denali Therapeutics Inc. ($DNLI) and Director in Vir Biotechnology, Inc. ($VIR) and Director in Beam Therapeutics Inc. ($BEAM) and in Karuna Therapeutics, Inc. ($KRTX) and Director in Karuna Therapeutics, Inc. ($KRTX) and Director in Lyell Immunopharma, Inc. ($LYEL) and Director in Sana Biotechnology, Inc. ($SANA).

ROBERT NELSEN in Juno Therapeutics, Inc.

Trading Symbol: JUNO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ROBERT NELSEN: Director
Holdings: 3,234 shares
Current Value: $67,138
Latest Transaction: Mar 07 2018
$JUNO Market Capitalization: $2.09B
$JUNO Previous Close: $20.76

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL

Last 3 Months Overview:
Buy: 8x
Sell: 3x
Shares Bought: 3,234
Shares Sold: 10,606,448
Share Difference: -10,603,214
Value Difference: +$922,760,960

Latest Insider Trading Transactions of ROBERT NELSEN in Juno Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AGIO, BEAM, BLPH, DNLI, JUNO, KRTX, KYTH, LYEL, SAGE, SANA, SNNA, SYRS, UBX, VIR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseD23.2912,000279,4800
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseD42.4012,000508,8000
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseD60.0012,000720,0000
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorSellU87.0010,552,390918,057,930010.6 M to 0 (-100.00 %)
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorSellD87.003,234281,35803.2 K to 0 (-100.00 %)
Mar 07 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorSellU87.0050,8244,421,6883,23454.1 K to 3.2 K (-94.02 %)
Jan 09 2018JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00237054,05853.8 K to 54.1 K (+0.44 %)
Oct 10 2017JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00254053,82153.6 K to 53.8 K (+0.47 %)
Jul 07 2017JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00400053,56753.2 K to 53.6 K (+0.75 %)
Jun 19 2017JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseA23.2912,000279,48012,000
Apr 06 2017JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00573053,16752.6 K to 53.2 K (+1.09 %)
Jan 09 2017JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00659052,59451.9 K to 52.6 K (+1.27 %)
Oct 17 2016JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00447051,93551.5 K to 51.9 K (+0.87 %)
Jul 05 2016JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00335051,48851.2 K to 51.5 K (+0.65 %)
Jun 21 2016JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseA42.4012,000508,80012,000
Apr 07 2016JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorGrantA0.00329051,15350.8 K to 51.2 K (+0.65 %)
Jun 16 2015JUNOJuno Therapeutics, ...NELSEN ROBERTDirectorOption ExerciseA60.0012,000720,00012,000

Page:   1